Companies /Healthcare

Moderna Inc

NASDAQ: MRNA Biotechnology
$199.00
▼ $7.80 (−3.77%) today
Markets open · 2:26pm ET
24/7 Rating HOLD
Our 12-month price target
$178.88
−11.2% downside by Nov 2027
Price when calculated $201.47 Nov 18, 2026
Street consensus $165.32 23 analysts
Ours vs. the Street +8.2% Our target vs. consensus

Set by 24/7 Wall St.’s proprietary analysis of professional targets, profit trajectory, sector, risk, and retail attention. Recalculated at least weekly and after every earnings report.

How we calculate it →
12-Month Projection Historical Optimistic Target Conservative
$60$120$180Nov 2025Nov 2027Nov 18$217.88$178.88$119.49
$60$120$180Nov 2025Nov 2027Nov 18$217.88$178.88$119.49

Analyst Sentiment

23ANALYSTS
Buy417%
Hold1565%
Sell417%
The Bottom Line

Moderna is fairly valued at current levels. With our price target of $178.88 suggesting limited downside, the stock appears to be trading near fair value. Consider your portfolio allocation and investment timeline before making a decision.

The 24/7 Factor

Base Growth
Conservative growth baseline (reduced to avoid double-counting P/E growth)
1.05×
Sector Momentum
Defensive growth with aging population tailwinds
1.10×
Earnings Growth
Significant earnings decline
−3.0%
Volatility Adjustment
Average volatility
−0.3%
Read our full methodology →

5-Year Projection

Long-Term Forecast Optimistic Target Conservative
$100$150$200$250’26’27’28’29’30’31$265.79$176.50$99.46
$100$150$200$250’26’27’28’29’30’31$265.79$176.50$99.46

Prediction History

MRNA Price Target History Our Target Stock Price
$100$150$200$250Aug 21Nov 13$171.46$223.37
$100$150$200$250Aug 21Nov 13$171.46$223.37
Date Price Target Stock Price Rating Upside
$171.46 $223.37 SELL −23.2%
$148.33 $254.19 SELL −41.6%
$148.89 $221.72 SELL −32.9%
$141.55 $200.10 SELL −29.3%
$135.48 $218.01 SELL −37.9%
$132.62 $225.00 SELL −41.1%
$133.10 $190.01 SELL −30.0%
$131.64 $198.88 SELL −33.8%

Frequently Asked Questions

What is the MRNA stock price prediction for 2030?

Looking ahead to 2030, our model projects MRNA could trade at an average price of $181.23, with a potential range between $135.92 and $226.54. This represents a potential 10.0% decline from today’s price. Long-term forecasts depend heavily on company execution, competitive dynamics, and broader market conditions.

Is MRNA a buy, sell, or hold right now?

24/7 Wall St. currently rates MRNA as a HOLD. Slight overvaluation (-11.2%) Among Wall Street analysts, 4 rate it Buy, 15 rate it Hold, and 4 rate it Sell.

What is the MRNA stock price target in an optimistic scenario?

Our optimistic scenario for MRNA projects a price of $217.88 over the next 12 months. This represents modest upside of 8.1% from today’s price, suggesting the stock may be fairly valued at current levels even under favorable conditions.

What is the downside risk for MRNA stock?

In our conservative scenario, MRNA could trade as low as $119.49 over the next 12 months, representing a 40.7% decline from current levels. This scenario accounts for potential headwinds including earnings misses, competitive pressures, or broader market weakness.

Projections are estimates based on current data, updated daily. Not investment advice. Learn how we calculate these projections →